{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:28:49Z","timestamp":1790015329019,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Ascendis Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12325-025-03265-w","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:31:13Z","timestamp":1750221073000},"page":"4881-4903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Economic Burden of Postsurgical Chronic Hypoparathyroidism: A US Medicare Claims Retrospective Analysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Wahidullah","family":"Noori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor V.","family":"Chirikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Roney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-534X","authenticated-orcid":false,"given":"Alden R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"3265_CR1","doi-asserted-by":"publisher","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, et al. Hypoparathyroidism. Nat Rev Dis Primers. 2017;3:17055.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"3265_CR2","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV, et al. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab. 2016;101(6):2273\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3265_CR3","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-18-0609","volume":"180","author":"AA Khan","year":"2019","unstructured":"Khan AA, Koch CA, Van Uum S, Baillargeon JP, Bollerslev J, Brandi ML, et al. Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol. 2019;180(3):P1\u201322.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"3265_CR4","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","volume":"186","author":"J Bollerslev","year":"2022","unstructured":"Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). Eur J Endocrinol. 2022;186(2):R33\u201363.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"3265_CR5","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/jbmr.4691","volume":"37","author":"AA Khan","year":"2022","unstructured":"Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Gittoes NJ, Pasieka JL, et al. Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop. J Bone Miner Res. 2022;37(12):2568\u201385.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"3265_CR6","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26(10):2317\u201337.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"3265_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40271-019-00388-5","volume":"13","author":"M Brod","year":"2020","unstructured":"Brod M, Waldman LT, Smith A, Karpf D. Assessing the patient experience of hypoparathyroidism symptoms: development of the hypoparathyroidism patient experience scale-symptom (HPES-symptom). Patient. 2020;13(2):151\u201362.","journal-title":"Patient"},{"issue":"7","key":"3265_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4158\/EP13328.OR","volume":"20","author":"N Hadker","year":"2014","unstructured":"Hadker N, Egan J, Sanders J, Lagast H, Clarke BL. Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study. Endocr Pract. 2014;20(7):671\u20139.","journal-title":"Endocr Pract"},{"key":"3265_CR9","doi-asserted-by":"crossref","unstructured":"Rubin MR. Recent advances in understanding and managing hypoparathyroidism. F1000Res. 2020;9.","DOI":"10.12688\/f1000research.22717.1"},{"issue":"3","key":"3265_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1210\/jendso\/bvac002","volume":"6","author":"MR Rubin","year":"2022","unstructured":"Rubin MR, Tabacco G, Omeragic B, Majeed R, Hale C, Brickman AM. A pilot study of cognition among hypoparathyroid adults. J Endocr Soc. 2022;6(3):2.","journal-title":"J Endocr Soc."},{"issue":"4","key":"3265_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359(4):391\u2013403.","journal-title":"N Engl J Med"},{"issue":"11","key":"3265_CR12","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to post-surgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013;28(11):2277\u201385.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"3265_CR13","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jbmr.2273","volume":"29","author":"L Underbjerg","year":"2014","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Postsurgical hypoparathyroidism\u2013risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res. 2014;29(11):2504\u201310.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"3265_CR14","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","volume":"30","author":"L Underbjerg","year":"2015","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res. 2015;30(9):1738\u201344.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"3265_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","volume":"38","author":"AA Khan","year":"2023","unstructured":"Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, et al. Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 PaTHway trial. J Bone Miner Res. 2023;38(1):14\u201325.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"3265_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11154-020-09613-1","volume":"22","author":"EO Gosmanova","year":"2021","unstructured":"Gosmanova EO, Houillier P, Rejnmark L, Marelli C, Bilezikian JP. Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review\u202f: renal disease in chronic hypoparathyroidism. Rev Endocr Metab Disord. 2021;22(2):297\u2013316.","journal-title":"Rev Endocr Metab Disord"},{"issue":"12","key":"3265_CR17","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-1808","volume":"97","author":"DM Mitchell","year":"2012","unstructured":"Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, et al. Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab. 2012;97(12):4507\u201314.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3265_CR18","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, Van Biesen W, et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1-20.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"3265_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1210\/jendso\/bvad050","volume":"7","author":"S Kaul","year":"2023","unstructured":"Kaul S, Gosmanova EO, Castriota F, Hitchens A, Candrilli S, Parikh R, et al. Recent trends in hypoparathyroidism-related inpatient and emergency department admissions and costs in the United States. J Endocr Soc. 2023;7(5):50.","journal-title":"J Endocr Soc"},{"issue":"1","key":"3265_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1210\/jendso\/bvab048.529","volume":"5","author":"D Murphy","year":"2021","unstructured":"Murphy D, Sanders B, Gulley L, Knoefler A, Smith A, Park M, et al. Disease burden of patients living with hypoparathyroidism: results from the voices of Hypopara survey. J Endocr Soc. 2021;5(1):260\u20131.","journal-title":"J Endocr Soc"},{"key":"3265_CR21","unstructured":"Chen K, Krasner A, Li N, Xiang CQ, Souroutzidis A, Xie J, editors. Clinical and economic burden associated with chronic hypoparathyroidism: a retrospective chart review in the United States, Canada, United Kingdom, France, Germany, Italy, and Spain. 99th Annual Meeting of the Endocrine Society; 2017: Endocrine Society."},{"issue":"11","key":"3265_CR22","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/13696998.2019.1624081","volume":"22","author":"K Chen","year":"2019","unstructured":"Chen K, Krasner A, Li N, Xiang CQ, Totev T, Xie J. Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs. not adequately controlled disease: a multi-country chart review. J Med Econ. 2019;22(11):1141\u201352.","journal-title":"J Med Econ"},{"issue":"6","key":"3265_CR23","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"Clarke BL, Brown EM, Collins MT, J\u00fcppner H, Lakatos P, Levine MA, et al. Epidemiology and diagnosis of hypoparathyroidism. J Clin Endocrinol Metab. 2016;101(6):2284\u201399.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"3265_CR24","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jbmr.2004","volume":"28","author":"J Powers","year":"2013","unstructured":"Powers J, Joy K, Ruscio A, Lagast H. Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res. 2013;28(12):2570\u20136.","journal-title":"J Bone Miner Res"},{"key":"3265_CR25","unstructured":"Faries D, Zhang X, Kadziola Z, Siebert U, Kuehne F, Obenchain RL, et al. Real world health care data analysis: causal methods and implementation using SAS: SAS Institute; 2020."},{"issue":"1","key":"3265_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25(1):1.","journal-title":"Stat Sci"},{"key":"3265_CR27","doi-asserted-by":"crossref","unstructured":"Chen K, Curhan G, Gosmanova EO, Rejnmark L, Swallow E, Macheca M, et al., editors. Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study. Endocrine Abstracts; 2019: Bioscientifica.","DOI":"10.1530\/endoabs.63.GP147"},{"key":"3265_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1530-891X(20)44221-1","volume":"23","author":"M Vera-Llonch","year":"2017","unstructured":"Vera-Llonch M, Krasner A. Economic burden of chronic hypoparathyroidism in US clinical practice. Endocr Pract. 2017;23:260.","journal-title":"Endocr Pract"},{"key":"3265_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03264-x","author":"W Noori","year":"2025","unstructured":"Noori W, Sibley CT, Chirikov VV, Roney K, Smith AR. Risk of cardiovascular events, infections, and renal complications in post-surgical chronic hypoparathoroidism: a US Medicare claims analysis. Adv Ther. 2025. https:\/\/doi.org\/10.1007\/s12325-025-03264-x","journal-title":"Adv Ther"},{"key":"3265_CR30","doi-asserted-by":"crossref","unstructured":"Gronemeyer K, Fuss CT, Hermes F, Plass A, Koschker A-C, Hannemann A, et al. Renal complications in chronic hypoparathyroidism\u2013a systematic cross-sectional assessment. Frontiers in Endocrinology. 2023;14.","DOI":"10.3389\/fendo.2023.1244647"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03265-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03265-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03265-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:09:10Z","timestamp":1758899350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03265-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3265"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03265-w","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article was updated due to correction in references","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Wahidullah Noori is an employee of Ascendis Pharma, which funded the study. Christopher T. Sibley is an employee of Ascendis Pharma, which funded the study. Viktor V. Chirikov is an employee of OPEN Health, which received consulting fees from Ascendis Pharma to conduct this study. Kyle Roney is an employee of OPEN Health, which received consulting fees from Ascendis Pharma to conduct this study. Alden R. Smith is an employee of Ascendis Pharma, which funded the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Due to the de-identified nature of the retrospective dataset, the study did not require ethics committee review. Permission for reuse of the Medicare 100% Limited Data Set was granted by its owner.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}